Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Measles-containing vaccine"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 655-673 (2024)
Introduction The global measles incidence has decreased from 145 to 49 cases per 1 million population from 2000 to 2018, but evaluating the economic benefits of a second measles-containing vaccine (MCV2) is crucial. This study reviewed the evidence a
Externí odkaz:
https://doaj.org/article/f4dde6663d364afeb9ed639b92d868b9
Autor:
Mingyan Li, Weiwei Zhang, Shuangshuang Zheng, Junxia Guo, Hanqing He, Yongjun Ma, Yan Huang, Yan Feng, Chai Ji
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThe waning of maternal antibodies may cause infants to lose protection against measles before receiving measles-containing vaccine (MCV). The aim of this study is to investigate the changing characteristics and influencing factors of measles
Externí odkaz:
https://doaj.org/article/a352e49b764543d6a766b4e7c088b0ee
Autor:
Ryoko Sato
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
IntroductionNigeria has one of the highest measles burdens and the lowest vaccination coverage in the world. Geographical disparity in the coverage has also been persistent. Between 2019 and 2021, the Nigerian government introduced the second Measles
Externí odkaz:
https://doaj.org/article/0b1e83fcb4694771944daf07f54ec28a
Autor:
Abyot Bekele Woyessa, Monica P. Shah, Binyam Moges Azmeraye, Jeff Pan, Leuel Lisanwork, Getnet Yimer, Shu-Hua Wang, J. Pekka Nuorti, Miia Artama, Almea M. Matanock, Qian An, Paulos Samuel, Bekana Tolera, Birhanu Kenate, Abebe Bekele, Tesfaye Deti, Getachew Wako, Amsalu Shiferaw, Yohannes Lakew Tefera, Melkamu Ayalew Kokebie, Tatek Bogale Anbessie, Habtamu Teklie Wubie, Aaron Wallace, Ciara E. Sugerman
Publikováno v:
Vaccines, Vol 12, Iss 7, p 762 (2024)
Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia’s routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We exami
Externí odkaz:
https://doaj.org/article/9b5b3d6aeb9a4137aaa7614e5887fcdf
Autor:
Dagmawi Chilot, Daniel Gashaneh Belay, Kegnie Shitu, Yibeltal Yismaw Gela, Mihret Getnet, Bezawit Mulat, Atalay Goshu Muluneh, Mehari Woldemariam Merid, Desalegn Anmut Bitew, Adugnaw Zeleke Alem
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Although a safe and effective vaccine is available, measles remains an important cause of mortality and morbidity among young children in Sub-Saharan Africa (SSA). The WHO and UNICEF recommended measles-containing vaccine dose 2 (
Externí odkaz:
https://doaj.org/article/49283860a681471099bbd1cfbbf3327a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas Jideofor Ogbu, Sarah Elizabeth Scales, Maria Moitinho de Almeida, Joris Adriaan Frank van Loenhout, Niko Speybroeck, Debarati Guha-Sapir
Publikováno v:
Archives of Public Health, Vol 80, Iss 1, Pp 1-9 (2022)
Abstract Background Quantifying the effect of measles containing vaccine (MCV) coverage and the prevalence of global acute malnutrition (GAM) on mortality levels in populations of displaced and crisis-affected resident children is important for inter
Externí odkaz:
https://doaj.org/article/39454298244e44e2af42523a0518cdfc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pierre Muhoza, Monica P. Shah, Hongjiang Gao, Kwame Amponsa-Achiano, Pamela Quaye, William Opare, Charlotte Okae, Philip-Neri Aboyinga, Kwadwo L. Opare, Melissa T. Wardle, Aaron S. Wallace
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1515 (2023)
Background: Understanding the drivers of coverage for vaccines offered in the second year of life (2YL) is a critical focus area for Ghana’s life course approach to vaccination. This study characterizes the predictors of vaccine receipt for 2YL vac
Externí odkaz:
https://doaj.org/article/8adc61ad342c44d38cc65473007f502c